Oncotarget

Research Papers:

A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer

Xue-Lian Xu, Hao Cheng, Meng-Si Tang, Hai-Liang Zhang, Rui-Yan Wu, Yan Yu, Xuan Li, Xiu-Min Wang, Jia Mai, Chen-Lu Yang, Lin Jiao, Zhi-Ling Li, Zhen-Mei Zhong, Rong Deng, Jun-Dong Li and Xiao-Feng Zhu _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:8120-8130. https://doi.org/10.18632/oncotarget.14100

Metrics: PDF 2553 views  |   HTML 2616 views  |   ?  


Abstract

Xue-Lian Xu1,*, Hao Cheng3,*, Meng-Si Tang1,2, Hai-Liang Zhang1, Rui-Yan Wu1, Yan Yu1, Xuan Li1, Xiu-Min Wang1, Jia Mai1, Chen-Lu Yang1,2, Lin Jiao1, Zhi-Ling Li1, Zhen-Mei Zhong1,2, Rong Deng1, Jun-Dong Li1,2, Xiao-Feng Zhu1

1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, Guangzhou 510060, China

2Department of Gynecological Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

3The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510060, China

*These authors have contributed equally to this work

Correspondence to:

Xiao-Feng Zhu, email: [email protected]

Jun-Dong Li, email: [email protected]

Keywords: LODDS, epithelial ovarian cancer, nomogram, prognosis, SEER

Received: July 20, 2016     Accepted: November 22, 2016     Published: December 22, 2016

ABSTRACT

BACKGROUND: To develop and validate a nomogram based on log of odds between the number of positive lymph node and the number of negative lymph node (LODDS) in predicting the overall survival (OS) and cancer specific survival (CSS) for epithelial ovarian cancer (EOC) patients.

MATERIALS AND METHODS: A total of 10,692 post-operative EOC patients diagnosed between 2004 and 2013 were obtained from the Surveillance, Epidemiology, and End Results (SEER) database and randomly divided into training (n = 7,021) and validation (n = 3,671) cohorts. Multiple clinical pathological parameters were assessed and compared with outcomes. Parameters significantly correlating with outcomes were used to build a nomogram. Bootstrap validation was subsequently used to assess the predictive value of the model.

RESULTS: In the training set, age at diagnosis, race, marital status, tumor location, stage, grade and LODDS were correlated significantly with outcome in both the univariate and multivariate analyses and were used to develop a nomogram. The nomogram demonstrated good accuracy in predicting OS and CSS, with a bootstrap-corrected concordance index of 0.757 (95% CI, 0.746-0.768) for OS and 0.770 (95% CI, 0.759-0.782) for CSS. Notably, in this population our model performed favorably compared to the currently utilized Federation of Gynecology and Obstetrics (FIGO) model, with concordance indices of 0.699 (95% CI, 0.688-0.710, P < 0.05) and 0.719 (95% CI, 0.709- 0.730, P < 0.05) for OS and CSS, respectively. Using our nomogram in the validation cohort, the C-indices were 0.757 (95% CI, 0.741-0.773, P < 0.05, compared to FIGO) for OS and 0.762 (95% CI, 0.746-0.779, P < 0.05, compared to FIGO) for CSS.

CONCLUSIONS: LODDS works as an independent prognostic factor for predicting survival in patients with EOC regardless of the tumor stage. By incorporating LODDS, our nomogram may be superior to the currently utilized FIGO staging system in predicting OS and CSS among post-operative EOC patients.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14100